Trials / Completed
CompletedNCT01440764
Aerosol Inhalation Treatment for Dyspnea
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this protocol is to develop and test optimal delivery of aerosol furosemide, a treatment that has the potential to significantly improve symptom management and enhance the quality of care for patients with intractable dyspnea.
Detailed description
This is study of aerosol treatment in a laboratory model of dyspnea in healthy subjects. This study is the first in a series of studies that will include investigation of a second dose in the laboratory and investigation of the treatment effect in hospitalized patients with refractory dyspnea. The outcome of this first study will determine the details of protocol for the succeeding studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Furosemide | |
| DRUG | Saline |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2016-04-01
- Completion
- 2017-04-01
- First posted
- 2011-09-27
- Last updated
- 2017-06-14
- Results posted
- 2017-06-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01440764. Inclusion in this directory is not an endorsement.